Home

Mark J Brooks

CIK 1424875 · last filed 2018-06-20

Mark J Brooks is a corporate insider who has filed 23 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for ALIM, was dated Jun 20, 2018. Across all open-market trades the lifetime net is +$3.0M, making them a net buyer over the disclosed history. 3 SEC filings were submitted jointly with KATE MITCHELL.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

23

Lifetime Open-Market Net

$2.97M

Filer Profile

Reported Address
C/O SCALE VENTURE MANAGEMENT
950 TOWER LANE, SUITE 400
FOSTER CITY, CA 94404
Related Filers
KATE MITCHELL — 3 joint filings, latest 2010-11-29
Rory O'Driscoll — 3 joint filings, latest 2010-11-29
Scale Venture Management II, LLC — 2 joint filings, latest 2010-11-29
Scale Venture Partners II, LP — 2 joint filings, latest 2010-11-29
Sharon L Wienbar — 2 joint filings, latest 2010-11-29
BAVP, L.P. — 1 joint filings, latest 2009-07-09
LOUIS C BOCK — 1 joint filings, latest 2009-07-09
Scale Venture Management I, LLC — 1 joint filings, latest 2009-07-09
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALIMERA SCIENCES INC (ALIM) Delisted Director 324,206 $5.54 $1.80M $4.00M 9 2018-06-20
IPC Healthcare, Inc. (IPCM) Delisted Director 1,748 — — $0 3 2015-01-05
IPC Healthcare, Inc. (OPTR) Delisted Director 963 — — -$1.03M 10 2013-07-24

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-06-20 ALIMERA SCIENCES INC (ALIM) Delisted Grant (A) — $0 EDGAR
2017-06-23 ALIMERA SCIENCES INC (ALIM) Delisted Grant (A) — $0 EDGAR
2016-06-24 ALIMERA SCIENCES INC (ALIM) Delisted Grant (A) — $0 EDGAR
2015-11-25 — Mixed −1,748 -$140.3K
2015-06-29 ALIMERA SCIENCES INC (ALIM) Delisted Grant (A) — $0 EDGAR
2015-01-05 IPC Healthcare, Inc. (IPCM) Delisted Mixed +544 $0 EDGAR
2014-07-24 IPC Healthcare, Inc. (IPCM) Delisted Exer (M) +241 $0 EDGAR
2014-01-03 IPC Healthcare, Inc. (IPCM) Delisted Grant (A) — $0 EDGAR
2013-07-24 IPC Healthcare, Inc. (OPTR) Delisted Exer (M) +482 $0 EDGAR
2013-06-20 ALIMERA SCIENCES INC (ALIM) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.